Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1956 1
1957 1
1958 3
1959 3
1960 3
1961 8
1962 18
1963 21
1964 21
1965 25
1966 34
1967 35
1968 33
1969 48
1970 60
1971 58
1972 35
1973 36
1974 50
1975 58
1976 50
1977 69
1978 72
1979 78
1980 84
1981 100
1982 98
1983 130
1984 118
1985 153
1986 148
1987 168
1988 211
1989 206
1990 184
1991 191
1992 205
1993 183
1994 243
1995 217
1996 262
1997 276
1998 274
1999 294
2000 281
2001 280
2002 314
2003 333
2004 340
2005 371
2006 391
2007 373
2008 412
2009 424
2010 424
2011 425
2012 511
2013 497
2014 530
2015 530
2016 554
2017 574
2018 591
2019 559
2020 642
2021 669
2022 644
2023 587
2024 417
2025 3

Text availability

Article attribute

Article type

Publication date

Search Results

14,818 results

Results by year

Filters applied: . Clear all
Page 1
Raludotatug Deruxtecan, a CDH6-Targeting Antibody-Drug Conjugate with a DNA Topoisomerase I Inhibitor DXd, Is Efficacious in Human Ovarian and Kidney Cancer Models.
Suzuki H, Nagase S, Saito C, Takatsuka A, Nagata M, Honda K, Kaneda Y, Nishiya Y, Honda T, Ishizaka T, Nakamura K, Nakada T, Abe Y, Agatsuma T. Suzuki H, et al. Mol Cancer Ther. 2024 Mar 4;23(3):257-271. doi: 10.1158/1535-7163.MCT-23-0287. Mol Cancer Ther. 2024. PMID: 38205802 Free PMC article.
An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized Trial.
Natsuaki M, Watanabe H, Morimoto T, Yamamoto K, Obayashi Y, Nishikawa R, Ando K, Domei T, Suwa S, Ogita M, Isawa T, Takenaka H, Yamamoto T, Ishikawa T, Hisauchi I, Wakabayashi K, Onishi Y, Hibi K, Kawai K, Yoshida R, Suzuki H, Nakazawa G, Kusuyama T, Morishima I, Ono K, Kimura T. Natsuaki M, et al. Among authors: suzuki h. Circulation. 2024 Feb 20;149(8):585-600. doi: 10.1161/CIRCULATIONAHA.123.066720. Epub 2023 Nov 23. Circulation. 2024. PMID: 37994553 Clinical Trial.
Effect of Recent Antirheumatic Drug on Features of Rheumatoid Arthritis-Associated Lymphoproliferative Disorders.
Hoshida Y, Tsujii A, Ohshima S, Saeki Y, Yagita M, Miyamura T, Katayama M, Kawasaki T, Hiramatsu Y, Oshima H, Murayama T, Higa S, Kuraoka K, Hirano F, Ichikawa K, Kurosawa M, Suzuki H, Chiba N, Sugiyama T, Minami Y, Niino H, Ihata A, Saito I, Mitsuo A, Maejima T, Kawashima A, Tsutani H, Takahi K, Kasai T, Shinno Y, Tachiyama Y, Teramoto N, Taguchi K, Naito S, Yoshizawa S, Ito M, Suenaga Y, Mori S, Nagakura S, Yoshikawa N, Nomoto M, Ueda A, Nagaoka S, Tsuura Y, Setoguchi K, Sugii S, Abe A, Sugaya T, Sugahara H, Fujita S, Kunugiza Y, Iizuka N, Yoshihara R, Yabe H, Fujisaki T, Morii E, Takeshita M, Sato M, Saito K, Matsui K, Tomita Y, Furukawa H, Tohma S. Hoshida Y, et al. Among authors: suzuki h. Arthritis Rheumatol. 2024 Jun;76(6):869-881. doi: 10.1002/art.42809. Epub 2024 Mar 13. Arthritis Rheumatol. 2024. PMID: 38272827
Lipid vesicle-based molecular robots.
Peng Z, Iwabuchi S, Izumi K, Takiguchi S, Yamaji M, Fujita S, Suzuki H, Kambara F, Fukasawa G, Cooney A, Di Michele L, Elani Y, Matsuura T, Kawano R. Peng Z, et al. Among authors: suzuki h. Lab Chip. 2024 Feb 27;24(5):996-1029. doi: 10.1039/d3lc00860f. Lab Chip. 2024. PMID: 38239102 Free PMC article. Review.
Real-world outcomes of nivolumab plus ipilimumab and pembrolizumab with platinum-based chemotherapy in advanced non-small cell lung cancer: a multicenter retrospective comparative study.
Matsumoto K, Shiroyama T, Tamiya M, Minami T, Kinehara Y, Tamiya A, Suga Y, Kuge T, Mori M, Suzuki H, Tobita S, Ueno K, Namba Y, Tetsumoto S, Niki T, Morimura O, Osa A, Nishino K, Nagatomo I, Takeda Y, Kijima T, Kumanogoh A. Matsumoto K, et al. Among authors: suzuki h. Cancer Immunol Immunother. 2024 Jan 4;73(1):4. doi: 10.1007/s00262-023-03583-4. Cancer Immunol Immunother. 2024. PMID: 38175294 Free PMC article.
Childhood cancer mutagenesis caused by transposase-derived PGBD5.
Yamada M, Keller RR, Gutierrez RL, Cameron D, Suzuki H, Sanghrajka R, Vaynshteyn J, Gerwin J, Maura F, Hooper W, Shah M, Robine N, Demarest P, Bayin NS, Zapater LJ, Reed C, Hébert S, Masilionis I, Chaligne R, Socci ND, Taylor MD, Kleinman CL, Joyner AL, Raju GP, Kentsis A. Yamada M, et al. Among authors: suzuki h. Sci Adv. 2024 Mar 22;10(12):eadn4649. doi: 10.1126/sciadv.adn4649. Epub 2024 Mar 22. Sci Adv. 2024. PMID: 38517960 Free PMC article.
Current Status of Robotic Gastrointestinal Surgery.
Minamimura K, Hara K, Matsumoto S, Yasuda T, Arai H, Kakinuma D, Ohshiro Y, Kawano Y, Watanabe M, Suzuki H, Yoshida H. Minamimura K, et al. Among authors: suzuki h. J Nippon Med Sch. 2023;90(4):308-315. doi: 10.1272/jnms.JNMS.2023_90-404. J Nippon Med Sch. 2023. PMID: 37690822 Free article. Review.
RNA Foci in Two bi-Allelic RFC1 Expansion Carriers.
Wada T, Doi H, Okubo M, Tada M, Ueda N, Suzuki H, Tominaga W, Koike H, Komiya H, Kubota S, Hashiguchi S, Nakamura H, Takahashi K, Kunii M, Tanaka K, Miyaji Y, Higashiyama Y, Koshimizu E, Miyatake S, Katsuno M, Fujii S, Takahashi H, Matsumoto N, Takeuchi H, Tanaka F. Wada T, et al. Among authors: suzuki h. Ann Neurol. 2024 Mar;95(3):607-613. doi: 10.1002/ana.26848. Epub 2023 Dec 27. Ann Neurol. 2024. PMID: 38062616
14,818 results
You have reached the last available page of results. Please see the User Guide for more information.